A. INTRODUCTION

1. Background and Qualifications

1. I have been practicing intellectual property law in Mexico since 1989. I studied Law at the Universidad Panamericana in Mexico City, and graduated with honors in 1989. I received a post-graduate degree in extraordinary constitutional procedures (amparo proceedings) from the former Institute of Judicial Specialization of the Supreme Court of the Nation (now the Institute of Federal Judiciary) (1990). I also hold a Master’s Degree in Constitutional and Administrative Law from the National Autonomous University of Mexico (UNAM) (1991-1993), and a Master’s Degree in Intellectual Property Law from George Washington University in Washington D.C. (1993-1994). I am currently pursuing my Doctorate at the Universidad Panamericana.

2. I am a Lecturer at Universidad Panamericana where I teach graduate level business law courses.

3. I am one of the founding partners of Arochi & Lindner, S.C. (A&L), an intellectual property law firm with offices in Mexico City, Barcelona and Madrid. Since its establishment in 1994, A&L has become recognized as one of the premier intellectual property law firms in Mexico. A&L has been rated a top-tier (“Band 1”) firm in Chambers & Partners’ publication Chambers Latin America, in 2011, 2012, 2013, 2014 and 2015.

4. My practice includes all types of intellectual property litigation, with a focus on pharmaceutical patents, and since 1996 I have been involved in a number of high profile pharmaceutical patent cases. I am counsel to the National Association of Medicine Manufacturers (ANAFAM in Spanish)1. During the entire legislative process that preceded the 2010 reforms to the Industrial Property Act (IPA),2 I participated as an industrial property expert, advising ANAFAM, which decided to support the 2010 Reform initiative. I have been invited to join the private delegation that accompanies Mexican negotiators to the negotiation rounds and meetings of the Intellectual Property Chapter of the Trans-Pacific Partnership Agreement (TPP).

5. I have written various articles for a number of publications, including most recently: “Recognizing Equivalence, Reciprocity and Respect” (Life and Sciences Intellectual Property Review, 2011); “A Question of Fairness: Preliminary Injunctions in Mexico” (Life and Sciences Intellectual Property Review, 2012) and “More Muscle: New Data Protection Guidelines in Mexico” (World Intellectual Property Review, November/December 2012). In Mexico, I recently published: “Medicamentos genéricos y medicamentos patentados: una disputa no resuelta” in OROPEZA GARCÍA, Arturo and GUÍZAR LÓPEZ, Victor Manuel (coordinators): "Los retos de la industria farmacéutica en el siglo XXI. Una visión comparada sobre su régimen de propiedad intelectual" (Universidad Nacional Autónoma de México, Institute of Legal Investigations, COFEPRIS, Mexico, 2010) and “Procesos de innovación y patentes farmacéuticas en el marco del Acuerdo de Asociación Trans-Pacífico (Trans-Pacific Partnership Agreement, TPP)” in OROPEZA GARCÍA, Arturo (coordinator); "El Acuerdo de Asociación Transpacífico ¿Bisagra o confrontación entre el Atlántico y el Pacífico?" (Universidad Nacional Autónoma de México, Institute of Legal Investigations, CEPAL, Mexico, 2013).